New strategies targeting the IDO enzyme in cancer, either through vaccine components directed against IDO epitopes or silencing the IDO gene using small hairpin RNA plasmids, are some of the strategies with potential application in the context of TB vaccination (118, 122). The gene discussed is IDO1; the disease is tuberculosis.